Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 February 2025 - 15:48

Human medicines European public assessment report (EPAR): Repaglinide Teva, repaglinide, Date of authorisation: 28/06/2009, Revision: 10, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/repaglinide-teva

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters